Showing results (91-100 of 478) with videos related to
Sort By:
Pageof 48
The American Journal of Cardiology|April 29, 1998
Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus GroupJ C Fruchart, H B Brewer, E LeitersdorfL'Encephale|November 21, 2022
Three clinical indicators of borderline personality disorder in anorexia nervosa: A pilot studyM Danon, P Duriez, P GorwoodEuropean Journal of Clinical Investigation|February 18, 1998
Fat ingestion is associated with increased levels of apoC-III- and apoE-B-containing lipoprotein particles in humansJ Dallongeville, E Baugé, P Lebel, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|January 15, 1979
[Lipoprotein electrophoresis on acrylamide-agarose plates, with discontinuous acrylamide gradient]S Moulin, J C Fruchart, P Dewailly, et al.Biochemical and Biophysical Research Communications|January 15, 1987
Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particlesR Barbaras, P Puchois, J C Fruchart, et al.Atherosclerosis|July 1, 1996
Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPARJ Auwerx, K Schoonjans, J C Fruchart, et al.Diabete & Metabolisme|September 1, 1977
[Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)]J Jaillard, G Sezille, P Dewailly, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Lack of triglyceride-lowering properties of fish oil in apolipoprotein e-deficient miceG Asset, E Baugé, J C Fruchart, et al.Biochimie|February 1, 1997
The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs)B Staels, K Schoonjans, J C Fruchart, et al.Current Medical Research and Opinion|May 21, 2010
Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i)J C Fruchart, F M Sacks, M P Hermans, et al.Pageof 48